These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
753 related articles for article (PubMed ID: 11528572)
1. Mass vaccination of children with pertussis toxoid--decreased incidence in both vaccinated and nonvaccinated persons. Taranger J; Trollfors B; Bergfors E; Knutsson N; Sundh V; Lagergård T; Lind-Brandberg L; Zackrisson G; White J; Cicirello H; Fusco J; Robbins JB Clin Infect Dis; 2001 Oct; 33(7):1004-10. PubMed ID: 11528572 [TBL] [Abstract][Full Text] [Related]
2. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis. Trollfors B; Taranger J; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB Clin Infect Dis; 1999 Mar; 28(3):552-9. PubMed ID: 10194077 [TBL] [Abstract][Full Text] [Related]
3. Pertussis after end of a mass vaccination project--end of the "vaccination honey-moon". Trollfors B; Dotevall L; Sundh V; Welinder-Olsson C Vaccine; 2011 Mar; 29(13):2444-50. PubMed ID: 21292010 [TBL] [Abstract][Full Text] [Related]
4. [Pertussis seroprevalence and vaccination status in three selected provinces of Turkey]. Kurtoğlu D; Gözalan A; Cöplü N; Miyamura K; Ishida S; Morita M; Akin L; Esen B Mikrobiyol Bul; 2008 Jul; 42(3):389-98. PubMed ID: 18822881 [TBL] [Abstract][Full Text] [Related]
5. [Time for booster doses against whooping cough for 10-year-old children]. Carlsson RM; Ekholm L; Gothefors L; Granström M; Trolin I; Tegnell A Lakartidningen; 2005 Aug 29-Sep 4; 102(35):2394-8. PubMed ID: 16184889 [TBL] [Abstract][Full Text] [Related]
6. [Vaccine protection of Swedish children. Time for revision of replacing doses of diphtheria, tetanus, polio and pertussis]. Olin P Lakartidningen; 2001 Aug; 98(35):3654-7. PubMed ID: 11577639 [TBL] [Abstract][Full Text] [Related]
8. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001. Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR; Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582 [TBL] [Abstract][Full Text] [Related]
9. Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine. Taranger J; Trollfors B; Bergfors E; Knutsson N; Lagergård T; Schneerson R; Robbins JB Pediatrics; 2001 Dec; 108(6):E115. PubMed ID: 11731642 [TBL] [Abstract][Full Text] [Related]
10. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. America Academy of Pediatrics Commitee on Infectious Diseases Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131 [TBL] [Abstract][Full Text] [Related]
11. Experience with diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine in Japan. Sato H; Sato Y Clin Infect Dis; 1999 Jun; 28 Suppl 2():S124-30. PubMed ID: 10447030 [TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age. Gustafsson L; Hessel L; Storsaeter J; Olin P Pediatrics; 2006 Sep; 118(3):978-84. PubMed ID: 16950988 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of acellular pertussis vaccine in young infants. Aoyama T; Iwata T; Iwai H; Murase Y; Saito T; Akamatsu T J Infect Dis; 1993 Feb; 167(2):483-6. PubMed ID: 8421187 [TBL] [Abstract][Full Text] [Related]
14. Examination of similarities between diphtheria and pertussis and their toxoids provide insight into vaccine-induced protection to Bordetella pertussis. Schneerson R; Robbins JB; Taranger J; Lagerård T; Trollfors B Dev Biol Stand; 1997; 89():321-6. PubMed ID: 9272366 [No Abstract] [Full Text] [Related]
15. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults. Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526 [TBL] [Abstract][Full Text] [Related]
16. The rise in pertussis cases urges replacement of chemically-inactivated with genetically-inactivated toxoid for DTP. Robbins JB; Schneerson R; Keith JM; Shiloach J; Miller M; Trollors B Vaccine; 2007 Apr; 25(15):2811-6. PubMed ID: 17291636 [TBL] [Abstract][Full Text] [Related]
17. Bordetella pertussis and Bordetella parapertussis infection in an Austrian pediatric outpatient clinic. Frühwirth M; Neher C; Schmidt-Schläpfer G; Allerberger F Wien Klin Wochenschr; 2002 Jun; 114(10-11):377-82. PubMed ID: 12708090 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of a monocomponent pertussis toxoid vaccine after household exposure to pertussis. Trollfors B; Taranger J; Lagergård T; Lind L; Sundh V; Zackrisson G; Bryla DA; Robbins JB J Pediatr; 1997 Apr; 130(4):532-6. PubMed ID: 9108848 [TBL] [Abstract][Full Text] [Related]
19. Impact of a pertussis booster vaccination program in adolescents and adults on the epidemiology of pertussis in Austria. Rendi-Wagner P; Paulke-Korinek M; Stanek G; Khanakah G; Kollaritsch H Pediatr Infect Dis J; 2007 Sep; 26(9):806-10. PubMed ID: 17721375 [TBL] [Abstract][Full Text] [Related]
20. Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: analyses of 10 years of pertussis surveillance. Nilsson L; Lepp T; von Segebaden K; Hallander H; Gustafsson L Vaccine; 2012 May; 30(21):3239-47. PubMed ID: 22094282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]